NovaVax News Flow Expected to Continue
Insights - It has been an eventful week for Novavax (NVAX), and we believe the news flow will spill over into next week. Biden’s Speech Included NovavaxOn … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Essa Dosing Cohorts Where Optimal Anti-tumor Effects Expected
Insights - Yesterday, Essa (EPIX) announced another collaboration, this time with Bayer. The two companies will run a combination of Essa’s EPI-7386 with Bayer’s Nubeqa (darolutamide) in patients with … Continue Reading
Premium
What to Expect for ASCO21
Research - The ASCO 2021 meeting is going to be June 4-8. This morning, ASCO 2021 abstract titles were released. May 19th is when selected abstracts (details other than just … Continue Reading
Premium
Mono AFM24 Has Some Uncertainty, But Real Potential Is In NK Combo
Insights - Affimed had their business update call this morning to primarily discuss updates on AFM24 and a few other items. Below are notes. Licensed NK Cells from MD … Continue Reading
PremiumNotes from Affimed’s KOL Call Discussing AACR NK+AFM13
Insights - Affimed(AFMD) hosted a call after market today to discuss cbNK+AFM13 data presented at AACR. KOL from MD Anderson Dr. Katy Rezvani was also on the call. Below … Continue Reading
PremiumA Look At Essa & Jounce Preclinical Data at AACR ’21
Insights - A look at pre-clinical data that Jounce and Essa presented at AACR this past weekend. Jounce (JNCE)Jounce has breached the $10/share level with a weak … Continue Reading
PremiumAffimed’s AACR Data Validates Bi-Specifics In NK Cell Combinations
Insights - Affimed (AFMD) released initial clinical data from the AFM13 + MD Anderson combo study at AACR this morning and it looked great. Ultimately, this data validates AFMD … Continue Reading
Premium